A study by Mount Sinai researchers has identified several pathophysiological mechanisms underlying perianal fistulae in Crohn’s disease. The findings highlight key transcription factor binding events and epigenetic phenomena that contribute to the higher rates of complications in African American patients. The research provides avenues...
Researchers revealed the biological mechanisms by which class II HDACs activate Th17 cell differentiation, leading to inflammation. A potent inhibitor, TMP269, was found to influence Th17 cell differentiation in a mouse model of ulcerative colitis, providing potential therapeutic approach for IBD treatment.
A study published in NEJM AI found that large language models are poor at reproducing original medical codes, highlighting the need for refinement and validation. Despite this, one model showed improved performance and potential applications for automating medical code extraction and billing accuracy.
Researchers identified alterations in the monkeypox virus genome that correlate with increased transmissibility, shedding light on the 2022 outbreak. The study's findings may help develop more effective prevention and treatment strategies.
Researchers have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems. A largely overlapping population of cells respond to both addictive drugs and natural rewards, leading to behavior directed toward drug-seeking and away from natural rewards.
Researchers found that withdrawing aspirin one month after PCI significantly reduced major and minor bleeding incidents by 55% compared to dual antiplatelet therapy. The study, ULTIMATE-DAPT, showed no increase in adverse ischemic events, suggesting continuing aspirin may cause harm without benefit.
A new study found that inter-atrial shunts improve symptoms and outcomes in heart failure patients with reduced left ventricular ejection fraction (LVEF), but worsen outcomes in those with preserved LVEF. The device reduces high pressures in the left atrium, causing shortness of breath and hospitalizations.
A Mount Sinai study found that primary care physicians' approach to selecting patients with comorbidities for lung cancer screening is influenced by subjective clinical judgments. The researchers recommend streamlined protocols and clearer guidelines to increase adoption of lung cancer screening for this high-risk population.
Researchers at Mount Sinai School of Medicine have identified macrophages as crucial in clearing lipid-rich waste from the brain. By studying genes controlling these immune cells, they discovered that two specific genes BHLHE40 and BHLHE41 regulate their activity.
Researchers used machine learning to identify key predictors of mortality in dementia patients across various types. The study found neuropsychological test results were a better predictor of mortality risk than age-related factors, highlighting the potential for personalized care and more effective interventions.
A long-term analysis of over 8,000 samples revealed that SARS-CoV-2 infection and vaccine-induced antibody responses are long-lasting. Booster vaccination equalized differences in antibody concentration between participants with and without pre-existing immunity.
A recent study has shed light on the vital role of the immune system in lung cancer risk, particularly among smokers. The research found that individuals with heterozygosity at HLA-II genes experienced a decreased risk of lung cancer.
A new study published in JAMA Ophthalmology suggests that artificial intelligence can match or exceed the expertise of seasoned ophthalmic specialists in diagnosing and treating patients with glaucoma and retina disorders. The AI system, GPT-4, demonstrated superior performance in response to glaucoma questions and case-management advice.
Using intravascular imaging to guide stent implantation significantly improves survival and reduces adverse cardiovascular events compared to angiography-guided PCI. The study found a 25% reduction in all-cause death, 45% reduction in cardiac death, and improved outcomes for patients with coronary artery disease.
A phase 2 study by Mount Sinai-led researchers demonstrates rusfertide's ability to limit excess red blood cell production in patients with polycythemia vera, a rare and chronic blood cancer. The results suggest it could replace therapeutic phlebotomy, providing improved treatment options for patients.
A study of over 1,000 tumors across 10 different cancers reveals complex interplay of immune cells in tumors. The research aims to identify patient groups more responsive to immunotherapy and develop new treatment strategies.
Researchers from Mount Sinai will present studies on preventing and treating fetal growth restriction, including the use of antenatal steroids and machine learning models for predicting surgical morbidity in placenta accreta spectrum. These findings aim to improve neonatal outcomes and maternal care.
A new study from the Icahn School of Medicine of Mount Sinai reveals significant variations in emergency medical service (EMS) performance across the United States. The research found that EMS agencies in rural areas were less likely to provide optimal care, including treating low blood sugar and pain for trauma patients.
Researchers at Mount Sinai Health System developed a novel protocol for rapid diagnosis of eye stroke, improving outcomes and preserving vision. The protocol uses high-resolution retinal imaging in emergency rooms, along with remote consultation, to confirm diagnosis and expedite care.
A global task force of scientists created an integrative framework to study emotions and moods, situating experiences within a single theoretical framework. This framework helps understand mental disorders like depression and anxiety, as well as decision-making and human behavior.
Researchers at Mount Sinai Hospital have discovered that circulating immune cells can be drawn to the brain during stress and alter emotional behavior. The study found that these immune cells release an enzyme called MMP8, which breaks down proteins in the brain and impairs social behavior.
A team of researchers has identified a way to turn on a vital bacterial defense mechanism to fight and manage bacterial infections. By leveraging the cyclic oligonucleotide-based antiphage signaling system (CBASS), bacteria can self-destruct to prevent viral attacks, offering a fresh approach to tackling antibiotic resistance.
The Eric and Wendy Schmidt AI in Human Health Fellowship Program will support five fellows over three years, leveraging AI to advance medical research and foster interdisciplinary collaborations. The program aims to attract exceptional talent and provide a platform for groundbreaking research.
Researchers discovered that cisplatin chemotherapy enhances the immune system's ability to fight bladder cancer by modulating the immune response and damaging DNA in cancer cells. This approach may lead to durable disease control in a subset of patients with metastatic bladder cancer.
The Icahn School of Medicine at Mount Sinai will investigate the pre-disease phase of Crohn's disease, identifying unique biomarkers to predict and prevent its development. The $4 million grant aims to transform healthcare by focusing on early intervention and prevention strategies.
Researchers discovered a previously unreported neuron type with vulnerability in Parkinson's disease, shedding light on the complexity of the disease and potential therapeutic targets. The study identified distinct transcriptomic signatures of this neuron type and found reduced RIT2 expression in Parkinson's disease patients.
Researchers harness AI power to predict right ventricle issues from electrocardiograms, promising more innovative tools and improved patient outcomes. The study departs from traditional methods, predicting something not easily quantifiable by other common tests.
Researchers unveiled mEnrich-seq, a method to enhance microbiome research specificity and efficiency. The technique helps identify specific bacteria in complex environments, facilitating study of diverse biomedical questions.
Researchers at Icahn School of Medicine at Mount Sinai developed a novel genetic priority score (GPS) to integrate various types of human genetic data for easy target prioritization. The tool identifies genes with high potential for clinical trial success, particularly those with demonstrated genetic support.
A Mount Sinai study found that human beliefs about nicotine can modulate brain activities in a way comparable to pharmacology, with potential implications for addiction treatment. The study used fMRI to explore the relationship between subjective beliefs and biological substrates in the human brain.
Researchers uncovered insights into TAAR1's mechanism of action, highlighting significant differences between human and rodent models. The study suggests species-specific differences in drug-receptor interactions, paving the way for improved medications targeting substance use disorders.
Researchers found strong associations between neighborhood prevalence of chronic conditions like CKD, diabetes, and hypertension and structural racism indicators. The study used data from Durham County, North Carolina, to explore the interplay between racism and poor health outcomes.
Researchers have gained a deeper understanding of the nuanced roles of JAK inhibitors in inflammation across various cell types and tissues. The study reveals that activating JAK1 signaling has tissue-specific effects, including an unexpected immunoregulatory role in lung sensory neurons, which suppresses lung inflammation.
A team of scientists has developed a statistical technique called BridgePRS to enhance disease prediction in people of non-European ancestry, particularly those of African descent. This advancement aims to reduce health care inequities and enable more personalized medical interventions based on genetic information.
The Mount Sinai Hospital has received a $1.3 million grant from the National Institutes of Health to expand its New York City Virus Hunters program. The program engages high school students in virus surveillance and mapping, tracking circulating avian influenza and paramyxoviruses in wild birds.
Researchers developed an innovative machine learning tool, LoGoFunc, to predict pathogenic gain- and loss-of-function variants across the human genome. The tool distinguishes between different types of harmful mutations, offering valuable insights into diverse disease outcomes.
Researchers identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer. Combining immunotherapy with dupilumab boosted patients' immune systems and showed significant tumor reduction in six out of six cases.
A new study found that traumatic memories in people with PTSD are represented in the brain in a distinct way, deviating from regular memory processing. The hippocampus and posterior cingulate cortex regions showed different neural responses to traumatic and sad autobiographical memories.
Mount Sinai researchers have found that testosterone treatment is safer than previously reported, with a smaller degree of change in hematocrit levels. The study, involving over 6,670 transmasculine patients, suggests that providers can feel more comfortable prescribing testosterone as part of gender-affirming hormone therapy.
A randomized controlled trial found that significant price discounts on healthful foods like vegetables and zero-calorie beverages lead to increased consumption of these items. The study suggests that subsidies or modifications to the Farm Bill could promote healthier dietary intake behaviors.
The Icahn School of Medicine at Mount Sinai has been awarded a $5 million NIH grant to establish a state-of-the-art center dedicated to discovering and developing novel therapeutic targets for cancer therapy. The Center will utilize cutting-edge technologies and interdisciplinary collaborations to accelerate the translation of scientif...
Researchers at Mount Sinai Center for Transformative Disease Modeling identified 4,749 key gene clusters that significantly influence the progression of 32 different types of cancer. The study provides a comprehensive resource for developing next-generation cancer treatments and diagnostic markers.
A new study published in Radiology shows that patients diagnosed with lung cancer via CT screening have a 20-year survival rate of 81 percent, significantly higher than the average five-year survival rate for all lung cancer patients. Early detection through routine screening can lead to a cure if found early.
Researchers shed light on TIMP2's role in regulating hippocampal plasticity and function, which decreases with age. Targeting the extracellular matrix may improve plasticity in the brain, offering new directions for mitigating neurodegenerative disorders.
A new study reveals that women with atrial fibrillation (AF) have comparable outcomes to men when undergoing pulsed field ablation (PFA), a safer and more precise procedure. The results show improved AF recurrence rates in women after PFA, making them an eligible candidate for this life-enhancing treatment.
A large brain autopsy study of women who experienced intimate partner violence found substantial vascular and white matter damage, but no evidence of chronic traumatic encephalopathy. The study also revealed significant medical comorbidity, including cardiovascular and cerebrovascular disease.
A recent study published in eBioMedicine found an association between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk of thyroid cancer. The researchers investigated plasma PFAS levels in thyroid cancer patients and non-cancer controls, finding a significant positive association with exposure to n-PFOS.
A clinical trial has shown that combining chemotherapy with immunotherapy nivolumab significantly improved outcomes in patients with advanced bladder cancer. The study found nearly twice as many patients with no evidence of disease after treatment, and a median complete response of 37.1 months.
Researchers created the first 'multiome' atlas of brain cell development in the human cerebral cortex, revealing specific changes in chromatin structure that precede gene expression. The study pinpointed regions associated with genes linked to neuropsychiatric disorders like schizophrenia and bipolar disorder.
Researchers from Icahn School of Medicine at Mount Sinai and the University of California San Diego will lead a new data integration hub aiming to accelerate novel therapeutics and cures for diseases. The grant, worth $8.5 million, is part of the NIH Common Fund's efforts to enhance data findability, accessibility, interoperability, an...